These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8625325)

  • 1. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.
    Miyake H; Hara I; Yoshimura K; Eto H; Arakawa S; Wada S; Chihara K; Kamidono S
    Cancer Res; 1996 May; 56(10):2440-5. PubMed ID: 8625325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H; Hara I; Gohji K; Yamanaka K; Hara S; Arakawa S; Nakajima M; Kamidono S
    Clin Cancer Res; 1999 Oct; 5(10):2824-9. PubMed ID: 10537348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.
    Miyake H; Yoshimura K; Hara I; Eto H; Arakawa S; Kamidono S
    J Urol; 1997 Jun; 157(6):2351-5. PubMed ID: 9146669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
    Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
    Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
    Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.
    Seki N; Hayakawa Y; Brooks AD; Wine J; Wiltrout RH; Yagita H; Tanner JE; Smyth MJ; Sayers TJ
    Cancer Res; 2003 Jan; 63(1):207-13. PubMed ID: 12517799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.
    Naito S; von Eschenbach AC; Giavazzi R; Fidler IJ
    Cancer Res; 1986 Aug; 46(8):4109-15. PubMed ID: 3731078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
    Miyake H; Hara I; Yamanaka K; Muramaki M; Gleave M; Eto H
    Oncol Rep; 2005 Feb; 13(2):341-5. PubMed ID: 15643522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J; Nakamoto T; Kasaoka Y; Usui T; Hamada H
    Hiroshima J Med Sci; 2000 Mar; 49(1):73-82. PubMed ID: 10824460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
    Inoue K; Slaton JW; Kim SJ; Perrotte P; Eve BY; Bar-Eli M; Radinsky R; Dinney CP
    Cancer Res; 2000 Apr; 60(8):2290-9. PubMed ID: 10786697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines.
    Qing J; Maher VM; Tran H; Argraves WS; Dunstan RW; McCormick JJ
    Oncogene; 1997 Oct; 15(18):2159-68. PubMed ID: 9393974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
    Ichikura H; Eto M; Ueno H; Harada M; Takayama K; Tokuda N; Tatsugami K; Naito S
    Oncol Rep; 2006 May; 15(5):1333-7. PubMed ID: 16596207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
    Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.
    Tan J; Newton CA; Djeu JY; Gutsch DE; Chang AE; Yang NS; Klein TW; Hua Y
    Cancer Res; 1996 Aug; 56(15):3399-403. PubMed ID: 8758901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
    Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.